ABSTRACT
Investigation of Frequency of Herpes Simplex Virus in Patients with Type 2 Diabetes and Healthy Individuals by PCR and ELISA
DNA extraction was carried out using commercial kits (Qiagene, Lot No: 11872534, Cat No: 51306) according to the manufacturer's instructions. Purity of the extracted DNA was analyzed by assessing absorbance at 260 and 280 nm using a BioPhotometer (Eppendorf, Germany). Human beta-globin gene was co-amplified with the target fragment, as an internal amplification control, using the following primers: Forward: 5'-TCC AAC ATC AAC ATC TTG GT-3' and Reverse: 5'-TCC CCC AAA TTC TAA GCA GA-3' (12).
The following specific primers were used for amplification of the UL30 gene: Forward: 5'-CAG TAC GGC CCC GAG TTC GTG A -3' and Reverse: 5'-GTA GTA GGT GCG GGT GAT GTT -3' (13). The primers were synthesized by TAG Copenhagen (Denmark). PCR was performed in a 25 µl reaction mixture containing 13 µl of molecular biology-grade water (Sigma Aldrich Company LTD., USA), 2.5 µl of 10× PCR buffer (Promega, USA), 1 µl of forward and reverse primers, 1 µl of 10 mM dNTPs (Promega, USA), 0. (1) . Several factors such as genetic susceptibility, obesity, age, high blood pressure, high blood lipids, and several environmental factors are associated with incidence of diabetes (2) . Determining the initial environmental factor is not simple because the exposure to the factor might have occurred many years before development of diabetes. A possible environmental factor is infection with different families of viruses (3) (4) (5) (6) (7) (8) (9) (10) . Herpesviridae is a large family of viruses that are pathogenic to humans. Identifying characteristics of these viruses, helps clarify their ability in causing latent infections (11 (11) . The aim of this study was to investigate prevalence of HSV in patients with type 2 diabetes and healthy controls using polymerase chain reaction (PCR) and enzymelinked immunosorbent assay (ELISA).
MATERIAL AND METHODS
This randomized cross-sectional study was conducted on 180 diabetic patients and 187 healthy blood donors (control group) referred to the Pasteur medical laboratory in Tonekabon, in 2016. Diabetes was confirmed in the participants via laboratory testing and by an internal medicine physician. Blood samples were taken from the participants after obtaining written consent. Effect of any underlying disorder including immunodeficiency, allergy, cancer, etc. was eliminated. After recording demographic information of the participants, 5 ml blood samples were taken and transferred to tubes containing EDTA. After centrifuging the samples, 50 μl of plasma was transferred to another sterile tube in order to perform ELISA. The remaining samples were stored at -20 o C until DNA extraction process. The frequency of HSV in diabetics and healthy individuals was determined in this study. Table 2 , there was a significant relationship between frequency of anti-HSV antibody with gender and age of the participants.
DISCUSSION
The prevalence of diabetes has increased notably in the past few decades. It is expected that the disease will affect more than 438 million individuals by 2030 (14). In Iran, diabetes is the most prevalent non-contagious disease with prevalence of 5.5% (15). Several studies have investigated the frequency of viral infections among diabetic patients and healthy individuals. The results of these studies confirmed the potential role of infection with some viruses including Parvovirus, Coxsackie B, Adenovirus, Rubella, Cytomegalovirus, and HSV in development of diabetes (1) (2) (3) (4) (5) 
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CONCLUSION
Similar to previous studies, the present study demonstrated the relationship between frequency of HSV infection and type 2 diabetes. However, further studies should be performed to eliminate the effect of other risk factors to help clarify the exact role of viral infections in increasing the risk of diabetes.
